Minako Yamaoka-Tojo

Summary

Affiliation: Kitasato University
Country: Japan

Publications

  1. ncbi Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome
    Minako Yamaoka-Tojo
    Department of Rehabilitation, Kitasato University School of Allied Health Sciences, 1 15 1 Kitasato, Minami Ku, Sagamihara, 252 0373 Kanagawa, Japan
    Nutr Metab (Lond) 8:3. 2011
  2. ncbi Ezetimibe and reactive oxygen species
    Minako Yamaoka-Tojo
    Department of Rehabilitation, Kitasato University School of Allied Health Sciences, 1 15 1 Kitasato, Minami Ku, Sagamihara, Kanagawa 252 0373, Japan
    Curr Vasc Pharmacol 9:109-20. 2011
  3. ncbi Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease
    Minako Yamaoka-Tojo
    Department of Rehabilitation, Kitasato University School of Allied Health Sciences, 1 15 1 Kitasato, Minami Ku, Sagamihara, 252 0373, Japan
    Cardiovasc Diabetol 9:17. 2010
  4. ncbi Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
    Minako Yamaoka-Tojo
    Department of Rehabilitation, Kitasato University School of Allied Health Sciences, 1 15 1 Kitasato, Sagamihara, Kanagawa 228 8555, Japan
    Lipids Health Dis 8:41. 2009
  5. ncbi Beyond cholesterol lowering: pleiotropic effects of bile acid binding resins against cardiovascular disease risk factors in patients with metabolic syndrome
    Minako Yamaoka-Tojo
    Department of Cardioangiology, Kitasato University School of Medicine, 1 15 1 Kitasato, Sagamihara, Kanagawa 228 8555, Japan
    Curr Vasc Pharmacol 6:271-81. 2008
  6. ncbi C-reactive protein-induced production of interleukin-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome
    Minako Yamaoka-Tojo
    Department of Internal Medicine and Cardiology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Heart Vessels 18:183-7. 2003
  7. ncbi Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure
    Minako Yamaoka-Tojo
    Department of Cardiology, Kitasato University School of Medicine, Sagamihara
    Intern Med 45:429-34. 2006
  8. ncbi Dual response to Fas ligation in human endothelial cells: apoptosis and induction of chemokines, interleukin-8 and monocyte chemoattractant protein-1
    Minako Yamaoka-Tojo
    The First Department of Internal Medicine, Yamagata University School of Medicine, Japan
    Coron Artery Dis 14:89-94. 2003
  9. ncbi Adaptation to low-intensity exercise on a cycle ergometer by patients with acute myocardial infarction undergoing phase I cardiac rehabilitation
    Atsuhiko Matsunaga
    Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Kanagawa, Japan
    Circ J 68:938-45. 2004
  10. ncbi Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure
    Minako Yamaoka-Tojo
    Department of Internal Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    J Card Fail 8:21-7. 2002

Collaborators

Detail Information

Publications13

  1. ncbi Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome
    Minako Yamaoka-Tojo
    Department of Rehabilitation, Kitasato University School of Allied Health Sciences, 1 15 1 Kitasato, Minami Ku, Sagamihara, 252 0373 Kanagawa, Japan
    Nutr Metab (Lond) 8:3. 2011
    ..abstract:..
  2. ncbi Ezetimibe and reactive oxygen species
    Minako Yamaoka-Tojo
    Department of Rehabilitation, Kitasato University School of Allied Health Sciences, 1 15 1 Kitasato, Minami Ku, Sagamihara, Kanagawa 252 0373, Japan
    Curr Vasc Pharmacol 9:109-20. 2011
    ....
  3. ncbi Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease
    Minako Yamaoka-Tojo
    Department of Rehabilitation, Kitasato University School of Allied Health Sciences, 1 15 1 Kitasato, Minami Ku, Sagamihara, 252 0373, Japan
    Cardiovasc Diabetol 9:17. 2010
    ..In spite of good effects of these drugs in diabetic patients, circulating levels of incretins and their role in MetS are largely unknown...
  4. ncbi Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
    Minako Yamaoka-Tojo
    Department of Rehabilitation, Kitasato University School of Allied Health Sciences, 1 15 1 Kitasato, Sagamihara, Kanagawa 228 8555, Japan
    Lipids Health Dis 8:41. 2009
    ..Ezetimibe has been reported to reduce LDL-C safely with both monotherapy and combination therapy with statins...
  5. ncbi Beyond cholesterol lowering: pleiotropic effects of bile acid binding resins against cardiovascular disease risk factors in patients with metabolic syndrome
    Minako Yamaoka-Tojo
    Department of Cardioangiology, Kitasato University School of Medicine, 1 15 1 Kitasato, Sagamihara, Kanagawa 228 8555, Japan
    Curr Vasc Pharmacol 6:271-81. 2008
    ....
  6. ncbi C-reactive protein-induced production of interleukin-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome
    Minako Yamaoka-Tojo
    Department of Internal Medicine and Cardiology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Heart Vessels 18:183-7. 2003
    ..This suggests that CRP may contribute to the mechanism of coronary artery disease in addition to being an incidental product of various types of systemic inflammation...
  7. ncbi Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure
    Minako Yamaoka-Tojo
    Department of Cardiology, Kitasato University School of Medicine, Sagamihara
    Intern Med 45:429-34. 2006
    ..Treatment of alpha-MSH could modify the immunobalance between inflammatory and anti-inflammatory responses in cultured PBMC. These findings suggest that alpha-MSH may play an important role in the pathophysiology of CHF...
  8. ncbi Dual response to Fas ligation in human endothelial cells: apoptosis and induction of chemokines, interleukin-8 and monocyte chemoattractant protein-1
    Minako Yamaoka-Tojo
    The First Department of Internal Medicine, Yamagata University School of Medicine, Japan
    Coron Artery Dis 14:89-94. 2003
    ..We also investigated whether an inhibitor of caspase-8 (Z-IETD-FMK) does modulate IL-8 and MCP-1 secretion...
  9. ncbi Adaptation to low-intensity exercise on a cycle ergometer by patients with acute myocardial infarction undergoing phase I cardiac rehabilitation
    Atsuhiko Matsunaga
    Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Kanagawa, Japan
    Circ J 68:938-45. 2004
    ..05), whereas there was no change in group A. CONCLUSION: Factors influencing a significant elevation of blood pressure during phase I rehabilitation are age, physical deconditioning, imbalance of autonomic nervous activity and anxiety...
  10. ncbi Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure
    Minako Yamaoka-Tojo
    Department of Internal Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    J Card Fail 8:21-7. 2002
    ..The findings suggest an important role for IL-18 in the pathophysiology of CHF and provide a direction for more specific immunomodulating therapy...
  11. ncbi Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia
    Taiki Tojo
    Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
    Circulation 111:2347-55. 2005
    ..The role of gp91phox-derived ROS in neovascularization in response to tissue ischemia is unknown, however...
  12. ncbi IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation
    Minako Yamaoka-Tojo
    Division of Cardiology Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
    Circ Res 95:276-83. 2004
    ....
  13. ncbi IQGAP1 regulates reactive oxygen species-dependent endothelial cell migration through interacting with Nox2
    Satoshi Ikeda
    Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
    Arterioscler Thromb Vasc Biol 25:2295-300. 2005
    ..We thus hypothesized that Nox2 and IQGAP1 may play important roles in ROS-dependent EC migration in response to injury...